THERAPEUTIC SEGMENT:
Pulmonology/ENT

INDICATIONS:
BILVEEZ is indicated for the symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.

BRIEF DESCRIPTION:
Bilveez (Bilastine) is a second‑generation, non‑sedating H₁‑antihistamine that selectively blocks peripheral histamine H₁ receptors, preventing histamine‑mediated allergic responses. It provides effective relief of allergic symptoms such as sneezing, itching, rhinorrhea and hives, with minimal influence on the central nervous system.

DOSAGE FORM:

Tablets
20mg